Loading resource…

Hospital Clínico Universitario de Valencia, Universitat de Valencia, CIBER Cardiovascular, Hospital Universitario Ramón y Cajal, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Germans Trias i Pujol Health Science
This review examines the utility of CA 125 as a biomarker for heart failure, focusing on its ability to quantify congestion and inflammation, which are key factors in disease progression and acute decompensation. The document details how CA 125 levels correlate with right-sided heart failure parameters and adverse clinical events, offering prognostic value beyond traditional markers like natriuretic peptides. It also discusses the emerging role of CA 125 in guiding treatment strategies, including adjustments to diuretic therapy and risk stratification during follow-up after hospital discharge.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology

PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology

OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology

CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology

The Athlete’s ECG
Same clinical topic · Cardiology

Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology

Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology

INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology

atherosclerosis-BK Presentation for Microlabs
Same clinical topic · Cardiology